Nurix Therapeutics (NRIX) FCF Margin (QoQ) (2020 - 2026)
Powered by 
Analysis
Nurix Therapeutics (NRIX) FCF Margin (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 10 | Nurix Therapeutics | 2.86 Bn | 2.42 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| May 31, 2026 | 9,538.00 |
| Feb 28, 2026 | -64,006.00 |
| Nov 30, 2025 | 22,389.00 |
| Aug 31, 2025 | -61,185.00 |
| May 31, 2025 | 20,049.00 |
| Feb 28, 2025 | 3,291.00 |
| Nov 30, 2024 | -2,913.00 |
| Aug 31, 2024 | -933.00 |
| May 31, 2024 | -7,404.00 |
| Feb 29, 2024 | -42,934.00 |
| Nov 30, 2023 | 39,506.00 |
| Aug 31, 2023 | -17,233.00 |
| May 31, 2023 | 33,619.00 |
| Feb 28, 2023 | 19,746.00 |
| Nov 30, 2022 | -13,657.00 |
| Aug 31, 2022 | -14,850.00 |
| May 31, 2022 | 16,687.00 |
| Feb 28, 2022 | -4,958.00 |
| Nov 30, 2021 | -11,905.00 |
| Aug 31, 2021 | 16,366.00 |